Vishnu Chemicals Limited share price

NSE: VISHNU · ISIN INE270I01022

Key numbers

Market cap
₹ 4,696 Cr
Current price
₹ 697.65
52-week high / low
₹ 744 / 444
Stock P/E
31.4
Book value
₹ 148.5
Dividend yield
0.04%
ROCE
15.5%
ROE
14.3%
Debt to equity
0.49
Sales growth (3 yrs)
4.9%
Profit growth (3 yrs)
1.4%
1-year return
42.3%

About Vishnu Chemicals Limited

Vishnu Chemicals Limited engages in the manufacture and sale of chromium chemicals in India and internationally. The company offers chromium chemicals, such as sodium dichromate, basic chromium sulphate, chromic acid, chrome oxide green, white sodium sulphate, and potassium dichromate; and barium barium carbonate, precipitated barium sulphate, strontium carbonate, and sodium sulphide. Its products are used in pharmaceuticals, pigments and dyes, infrastructure, ceramics and tiles, automobiles, furniture, paints and coatings, bathroom fittings, leather, construction, automotive and mechanical components, and refractories. Vishnu Chemicals Limited was incorporated in 1989 and is headquartered in Hyderabad, India.

Quarterly results

Consolidated figures in ₹ crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales346400409448432
Operating profit5658627765
Net profit3233344340
EPS (₹)4.794.885.026.495.89

Concall summary (2026-08-05)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

  • On a consolidated basis, the company reported operating revenues of INR433.4 crores in Q1 FY27 compared to INR346.9 crores in Q1 FY26, a growth of 24.9% Y-o-Y.
  • The gross profit for the quarter stood at INR193.9 crores compared to INR158.2 crores in Q1 FY26, a growth of 22.6% Y -o-Y.

Growth & demand

  • Despite an uncertain global environment, we believe we have delivered over 20% year-on-year growth in both operating revenue and PAT, reflecting the underlying strength and resilience of our business.
  • The profit after tax for the quarter stood at INR39.6 crores compared to INR32.2 crores in Q1 FY26, a growth of 23% Y-o-Y.

Margins & costs

  • EBITDA margin stood at 15.1% in Q1 FY27 compared to 16.1% in corresponding quarter last year.
  • But we always look at the blended realization and overall product mix ideally to achieve a 25% EBITDA margin.

Capex & expansion

  • We are planning to add approximately 20 megawatts of solar power capacity, which will increase our solar power generation capacity, nearly 6x from the current level, whereby the average power cost will come down significantly over the years.
  • Like currently, we are operating a 5 -megawatt solar power plant, out of which the realizable power will be close to 55%, 60%.

Balance sheet & cash

  • And this will give us a lot more leverage in terms of product mix, what we want to take it up in the quarters to come.
  • So our -- as per the balance sheet that we have reported ending 31st March, the total debt in our books is about INR527 crores.

Peers in Specialty Chemicals

Data for information only, not investment advice. Prices end of day.